Estratégia de estratificação de risco: aplicabilidade do instrumento de avaliação de risco em usuários do Centro de Referência em Condições Crônicas em Balsas-MA

Abstract

This research sought to address risk stratification strategies through the applicability of the risk assessment instrument to users of the referral center for chronic conditions in Balsas-MA. Its general objective is to elaborate and propose risk stratification strategies in users of the reference center in chronic conditions through the risk assessment instrument in the city of Balsas-MA. This is a descriptive research, with a quantitative approach. A form was applied to adults and elderly people who attended the Outpatient Clinic Specialized in Chronic Diseases. To determine the number of research participants, it was through spontaneous demand between the months of October 2021 to April 2022, which resulted in 200 participants. The data obtained from the form were organized through sociodemographic data (age) and anthropometric measurements (weight, height, BMI and waist circumference), lifestyle (physical exercise, eating habits and family history of diabetes) and clinical data. (personal and family history of other comorbidities, blood pressure and capillary glycemia). It was observed in the results that 19 (5.5%) have low risk, 16 (8%) slightly high risk, 55 (27.5%) moderate risk, 65 (32.5%) high risk and 45 (22.5%) %) very high risk of developing DM2 in 10 years, with 140 (70%) women and 60 (30%) men, with a higher prevalence between 55 and 64 years old 46 (23%), with high BMI 106 (53% ), obesity 40 (20%) and severe obesity 04 (2%), with abdominal circumference greater than 94 cm in men 41 (20.5%) and abdominal circumference greater than 88 cm in women 122 (61%), unless performing any type of physical exercise 103 (51.5%), inadequate eating habits 98 (49%), family history of DM 119 (59.5%), personal history of other comorbidities 118 (59%), family history of other comorbidities 173 (86.5%), blood pressure ≥ 121-139/81-89 mmHg 118 (59%) and capillary blood glucose lower than 200 mg/dl 131 (65.6%). It is hoped that this research will provide subsidies for the development of others, in the search for effective strategies for the stratified population at risk for developing DM2. In addition, that it serves as subsidies for the early detection of DM2 and intervention through a support network between the primary and tertiary health levels, depending on the individual's situation.